A Hydrogel‐Mediated Sustained‐Release Platform Alters the Biodistribution of Umbilical Cord Mesenchymal Stem Cell‐Derived Extracellular Vesicles in Mice
Advanced Healthcare Materials · 2026-06 · 15 (23)
DOI: 10.1002/adhm.71210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 10.05.2026. Verfasst von Zongbin Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Umbilical Cord, Hydrogels, Extracellular Vesicles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of China regional project, Gansu Provincial General Surgery Clinical Medical Research Center.
Abstract (Originalsprache)
Mesenchymal stem cell‐derived exosomes represent a promising therapeutic avenue for tissue regeneration, yet their clinical translation is hindered by rapid clearance following systemic administration and the lack of optimized, sustained‐release delivery strategies. To address these challenges, we crafted a biomimetic hydrogel to carry and gently release MSC‐derived exosomes. We engineered a biocompatible, dextran‐based composite hydrogel (carboxymethyl chitosan‐oxidized dextran/tannic acid‐iron complex, CMC‐OD/TA‐Fe(III)) for the encapsulation and sustained release of human umbilical cord MSC‐derived exosomes. We systematically compared the organ biodistribution of exosomes delivered via this hydrogel platform using three distinct local routes: intraperitoneal injection, oral (intragastric) administration, and rectal administration, employing in vivo imaging and tissue immunofluorescence analyses in C57BL/6J mice. Following a single intraperitoneal dose, released exosomes accumulated primarily in the liver and spleen, with minimal brain enrichment. Notably, both oral and rectal administration—non‐invasive alternatives to injection—facilitated considerable exosome dissemination to multiple organs. The significant distribution observed via the oral route specifically challenges the prevailing assumption regarding the inefficacy of gastrointestinal delivery for exosome‐based therapeutics. This study provides critical insights into administration‐route‐dependent biodistribution patterns and proposes novel, non‐invasive delivery strategies to enhance the therapeutic efficacy and application scenarios of exosomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Clinical Medical College, Lanzhou University, Lanzhou, China.
- General Surgery Department, First Hospital of Lanzhou University, Lanzhou University, Lanzhou, China.
- State Key Laboratory of Solid Lubrication Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou, China.
- Key Laboratory of Biotherapy and Regenerative Medicine, First Hospital of Lanzhou University, Lanzhou University, Lanzhou, China.
ORCID-Profile: Qiuxia Zheng, Desheng Liu, Jia Yao, Xun Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of China regional project
- Gansu Provincial General Surgery Clinical Medical Research Center
- Gansu Province Traditional Chinese Medicine Industry Innovation Consortium Project
- Gansu Province Science and Technology Plan Project
- International cooperation field of major scientific and technological projects
- Special Projects for Scientific and Technological Achievements and Applications of Gansu Province
- Talent Innovation and Entrepreneurship Project
Zitieren
APA
Sun, Z., Zheng, Q., Bai, C., Liu, D., Zhang, Y., Yang, P., Wang, F., Li, R., Yao, J., & Li, X. (2026). A Hydrogel‐Mediated Sustained‐Release Platform Alters the Biodistribution of Umbilical Cord Mesenchymal Stem Cell‐Derived Extracellular Vesicles in Mice. Advanced Healthcare Materials, 15(23). https://doi.org/10.1002/adhm.71210
Vancouver
Sun Z, Zheng Q, Bai C, Liu D, Zhang Y, Yang P, et al. A Hydrogel‐Mediated Sustained‐Release Platform Alters the Biodistribution of Umbilical Cord Mesenchymal Stem Cell‐Derived Extracellular Vesicles in Mice. Advanced Healthcare Materials. 2026;15(23). doi:10.1002/adhm.71210
BibTeX
@article{Sun2026,
author = {Sun, Zongbin and Zheng, Qiuxia and Bai, Chongyang and Liu, Desheng and Zhang, Yue and Yang, Ping and Wang, Fanghong and Li, Rui and Yao, Jia and Li, Xun},
title = {A Hydrogel‐Mediated Sustained‐Release Platform Alters the Biodistribution of Umbilical Cord Mesenchymal Stem Cell‐Derived Extracellular Vesicles in Mice},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {23},
doi = {10.1002/adhm.71210}
}
EUVIMED